Get your free ETF data sample from our comprehensive offerings. Start your free trial

Help us improve your experience. Please confirm your investor type:

ETF What's Up

Don’t Miss a Move in the ETF Market

Sign up and keep track of everything that moved the ETF industry this week. From new launches to regulatory shifts across the Atlantic.

ETF What's Up

You may unsubscribe at any time by clicking the “unsubscribe” link within the emailed newsletter. By signing up, you agree to our Privacy Policy and Terms and Conditions.

143860

Mirae Asset TIGER HEALTH CARE ETF

Passive ETFEquity
Not rated

The 143860 Exchange Traded Fund (ETF) is provided by Mirae Asset Global Investments. It is built to track an index: Korea KRX Health Care Index. The 143860 ETF provides physical exposure, so by buying it you actually own parts of all the 67 underlying holdings. This share class generates a stream of income by distributing dividends.

Advertisement

Advertisement

₩37,170
-₩75 (-0.20%) today
12:00 AM 09/07/26 Closed
1D price range
₩36,905₩37,405
52W price range
₩32,280₩56,000
YTD Perf.
-22.20%
YTD Flows
Annualized volatility
Fund AuM
€96M
Share class AuM
€96M
TTM Yield
Tracking Error
Tracking Difference
ISIN
KR7143860005
TER
0.4%
Inception date
7/18/2011
Replication method
Dividend policy
Compare similar ETFs
API
PerformanceDec 30, 2025 - Sep 4, 2026
-30%-20%-10%0%10%20%JANMARMAYJULSEP
Flows
Join for free to unlock
Data as of 07/31/26
Healthcare
94.72%
Industrials
3.15%
Consumer Non-Cyclicals
1.24%
Unavailable
0.20%
Other
0.69%
Latest 143860 news

No content available for this fund

FAQ about 143860

143860 is a Passive ETF. This ETF provides exposure to South Korean Health Care Equities.
143860 tracks the Korea KRX Health Care Index - KRW, through a full replication replication method.
143860 carries a total expense ratio (TER) of 0.4%, indicating the annual cost for holding the fund.
143860 was introduced to the market on July 18, 2011. It trades on Tanzania, United Republic of, among other exchanges
Mirae Asset TIGER HEALTH CARE ETF, 143860, is provided by Mirae Asset Global Investments. Learn more about Mirae Asset Global Investments here.
143860 oversees €96M in assets as of September 4, 2026.
143860 follows a distributing dividend policy, meaning it pays out income to investors. As of September 4, 2026, its 12-month trailing yield was 0.19%.
As of July 31, 2026, 143860 has significant geographic allocations in Republic of Korea.
As of July 31, 2026, 143860 focuses largely on Healthcare, Industrials and Consumer Non-Cyclicals.
As of July 31, 2026, 143860 holds 67 positions in its portfolio, with 76.19% of assets concentrated in its top 15 holdings.
As of July 31, 2026, 143860 top three holdings include Celltrion, Inc., SAMSUNG BIOLOGICS Co., Ltd. and Alteogen, Inc..
The base currency of 143860 is KRW.
Data as of 07/31/26
Celltrion, Inc.
24.98%
SAMSUNG BIOLOGICS Co., Ltd.
13.27%
Alteogen, Inc.
11.03%
Yuhan Corp.
3.86%
HLB Co., Ltd.
3.15%
SK Biopharmaceuticals Co., Ltd.
2.71%
ABL Bio, Inc.
2.43%
Peptron, Inc.
2.41%
PharmaResearch Co., Ltd.
2.05%
LigaChem Biosciences, Inc.
1.99%

Trackinsight
Essentials

A forever free toolbox for fund selection, analysis, research, and ETF portfolio construction.

Essential free account includes:
  • More fund data
  • Compare up to 3 funds
  • More screener filters
  • Edit screener columns from 100+ metrics
  • Watchlists for saving your research
  • Portfolio construction and analysis
  • Personal dashboard for live monitoring

Advertisement

Trackinsight

About Trackinsight

Since our founding in 2016, we have been at the forefront of the industry, delivering accessible, comprehensive, and reliable tools to support the evolving needs of investors.

Over the past decade, Trackinsight has expanded its operations across six countries, serving thousands of professional investors. We’ve consistently innovated to provide cutting-edge solutions that meet the changing demands of the ETF market.

In 2024, Kepler Cheuvreux, a leading independent European financial services firm, acquired a majority stake in Trackinsight, becoming the company's principal shareholder.

This strategic partnership solidifies Trackinsight's position as a premier provider of ETF selection and analysis tools, while strengthening Kepler Cheuvreux’s commitment to becoming a leading player in the ETF sector.

Together, we are committed to offering advanced services that empower professional investors, advisors, institutions, and issuers. This new step enables us to deliver even more comprehensive and innovative technological solutions, driving ETF investing to new heights.

More about Trackinsight
© 2014-2026 Trackinsight SA. All rights reserved.
Privacy policy  |  Cookie policy  |    |  Terms of use  |  Imprint
Trackinsight